RA PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
RA PHARMACEUTICALS, INC. reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $19.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-12-31 was -$197.00K.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-09-30 was $114.00K, a 9.62% increase year-over-year.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-06-30 was $110.00K, a 44.74% increase year-over-year.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2018-03-31 was -$8.00K, a 142.11% decline year-over-year.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2018 was $19.00K, a 0.00% change from fiscal 2017.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2017 was $19.00K.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2016 was -$22.00K, a 137.29% decline from fiscal 2015.
- RA PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2015 was $59.00K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$83.00K derived: sum of 2 quarters · filed 2020-02-27 | $27.00K derived: sum of 3 quarters · filed 2020-02-27 | $19.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $224.00K derived: sum of 2 quarters · filed 2019-11-07 | $216.00K 10-Q · filed 2019-11-07 | $36.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $102.00K 10-Q · filed 2019-08-07 | -$78.00K derived: sum of 3 quarters · filed 2019-08-07 | $26.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$8.00K 10-Q · filed 2019-05-09 | -$188.00K derived: sum of 2 quarters · filed 2019-05-09 | -$84.00K derived: sum of 3 quarters · filed 2019-05-09 | -$8.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$76.00K derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $19.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $180.00K derived: sum of 2 quarters · filed 2018-11-07 | $199.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $95.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $19.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | -$22.00K 10-K · filed 2018-03-14 | |||
| 2015-12-31 | $59.00K 10-K · filed 2018-03-14 |